Search research articles
Contact Us
Filters
Showing results (201-210 of 208) with videos related to
Page
of 21
Sort By:
You have reached the last page of results.
This site can display upto 208 results.
Cancers
|
March 4, 2020
Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging
Yan Jin, James W Randall, Hesham Elhalawani, et al.
Journal of Crohn'S & Colitis
|
March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease
Matthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Gut Microbes
|
November 24, 2024
Cerebrovascular damage caused by the gut microbe/host co-metabolite <i>p</i>-cresol sulfate is prevented by blockade of the EGF receptor
Sita N Shah, Tobias B-A Knausenberger, Matthew G Pontifex, et al.
Journal of Translational Medicine
|
September 16, 2020
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection
Donogh Maguire, Marylynne Woods, Conor Richards, et al.
Alimentary Pharmacology & Therapeutics
|
June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study
W J Sandborn, G Y Melmed, D P B McGovern, et al.
Cancer Research
|
September 20, 2017
Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes Carcinogenesis
Ches'Nique M Phillips, John R Zatarain, Michael E Nicholls, et al.
Plos One
|
May 27, 2021
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts
Donogh Maguire, Conor Richards, Marylynne Woods, et al.
Neuro-Oncology Advances
|
August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment
Karine A Al Feghali, James W Randall, Diane D Liu, et al.
Page
of 21
Search research articles
Search
Showing results (201-210 of 208) with videos related to
Sort By:
Page
of 21
You have reached the last page of results.
This site can display upto 208 results.
Cancers
|
March 4, 2020
Detection of Glioblastoma Subclinical Recurrence Using Serial Diffusion Tensor Imaging
Yan Jin, James W Randall, Hesham Elhalawani, et al.
Journal of Crohn'S & Colitis
|
March 20, 2023
A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn's Disease
Matthieu Allez, Bruce E Sands, Brian G Feagan, et al.
Gut Microbes
|
November 24, 2024
Cerebrovascular damage caused by the gut microbe/host co-metabolite <i>p</i>-cresol sulfate is prevented by blockade of the EGF receptor
Sita N Shah, Tobias B-A Knausenberger, Matthew G Pontifex, et al.
Journal of Translational Medicine
|
September 16, 2020
Prognostic factors in patients admitted to an urban teaching hospital with COVID-19 infection
Donogh Maguire, Marylynne Woods, Conor Richards, et al.
Alimentary Pharmacology & Therapeutics
|
June 3, 2015
Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7-year PRECiSE 3 study
W J Sandborn, G Y Melmed, D P B McGovern, et al.
Cancer Research
|
September 20, 2017
Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes Carcinogenesis
Ches'Nique M Phillips, John R Zatarain, Michael E Nicholls, et al.
Plos One
|
May 27, 2021
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts
Donogh Maguire, Conor Richards, Marylynne Woods, et al.
Neuro-Oncology Advances
|
August 2, 2021
Phase II trial of proton therapy versus photon IMRT for GBM: secondary analysis comparison of progression-free survival between RANO versus clinical assessment
Karine A Al Feghali, James W Randall, Diane D Liu, et al.
Page
of 21